The antiapoptotic members of the family, bcl-2 and bcl-XL, and the proapoptotic member bax are reportedly expressed in 15, 74 and 81%, respectively, of laryngeal biopsy samples from advanced laryngeal tumours (Trask et al, 2002). Here, BCL2 is linked to laryngeal neoplasm.